this is who we are
Founded in Israel in 1975, Unipharm is a well-established, family-owned generic pharma company, and a dominant player in the Israeli pharmaceutical arena. Unipharm’s strength in developing generic oral solid and oral solution formulations has led it to become one of the Israeli Market leaders. Unipharm is usually the first generic entrance into the Israeli Market.
Many of Unipharm’s new generic product launches have made an extensive impact on the Israeli Pharmaceutical Market by improving and accelerating patient accessibility to affordable medicines.
Our new, EU-recognized, GMP certified manufacturing facility, opened in 2017, offers the latest technology in oral solid and oral solution development and production. Our generic portfolio spans a wide range of therapeutic areas, including unique niche opportunities.
We’ve made a name for ourselves through our involvement in the shaping and development of intellectual property laws in Israel. Our legal achievements in pharmaceutical patent cases have led to a consistent track record of successful and early generic launches.
Since 2017, Unipharm has been collaborating with international generic players, enabling its customers to launch its high-quality products around the world. Unipharm’s generics are offered for out-licensing to all international markets. Our EU CTD dossiers are available along with full regulatory support to achieve successful and swift marketing approvals. Zone IVb stability data is also available.